A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology: The TAXi trial
- 18 January 2005
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 45 (2) , 308-311
- https://doi.org/10.1016/j.jacc.2004.10.062
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Use of sirolimus‐eluting coronary stents in routine clinical practiceCatheterization and Cardiovascular Interventions, 2004
- Inhibition of Restenosis With a Paclitaxel-Eluting, Polymer-Free Coronary StentCirculation, 2004
- The Paclitaxel (TAXUS???)-Eluting StentAmerican Journal of Cardiovascular Drugs, 2004
- Paclitaxel-eluting stents: are they all equal? An analysis of six randomized controlled trials in de novo lesions of 3,319 patients.Journal of Interventional Cardiology, 2003
- TAXUS ICirculation, 2003
- The Sirolimus-Eluting StentAmerican Journal of Cardiovascular Drugs, 2003
- A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary RevascularizationNew England Journal of Medicine, 2002
- A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1994
- A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery DiseaseNew England Journal of Medicine, 1994